Brown Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.02M Sell
84,592
-207,209
-71% -$17.2M 0.01% 459
2025
Q1
$23.7M Sell
291,801
-36,419
-11% -$2.95M 0.03% 295
2024
Q4
$29.6M Sell
328,220
-687,813
-68% -$61.9M 0.04% 285
2024
Q3
$100M Sell
1,016,033
-74,328
-7% -$7.34M 0.13% 131
2024
Q2
$101M Sell
1,090,361
-578,741
-35% -$53.7M 0.13% 124
2024
Q1
$158M Buy
1,669,102
+107,922
+7% +$10.2M 0.21% 88
2023
Q4
$139M Sell
1,561,180
-51,664
-3% -$4.61M 0.2% 93
2023
Q3
$118M Sell
1,612,844
-136,602
-8% -$9.97M 0.19% 99
2023
Q2
$146M Sell
1,749,446
-166,191
-9% -$13.8M 0.23% 94
2023
Q1
$146M Buy
1,915,637
+34,532
+2% +$2.63M 0.25% 93
2022
Q4
$156M Buy
1,881,105
+910,850
+94% +$75.6M 0.29% 85
2022
Q3
$77M Buy
970,255
+889,912
+1,108% +$70.6M 0.15% 125
2022
Q2
$5.97M Buy
80,343
+1,511
+2% +$112K 0.01% 434
2022
Q1
$7.09M Buy
78,832
+24,487
+45% +$2.2M 0.01% 433
2021
Q4
$6.08M Sell
54,345
-13,265
-20% -$1.49M 0.01% 455
2021
Q3
$8.5M Sell
67,610
-5,235
-7% -$658K 0.01% 386
2021
Q2
$9.86M Buy
72,845
+2,095
+3% +$284K 0.01% 380
2021
Q1
$9.6M Buy
70,750
+15,429
+28% +$2.09M 0.02% 357
2020
Q4
$7.79M Buy
55,321
+45,810
+482% +$6.45M 0.01% 374
2020
Q3
$1.06M Buy
9,511
+100
+1% +$11.1K ﹤0.01% 602
2020
Q2
$1.05M Buy
9,411
+1,055
+13% +$118K ﹤0.01% 585
2020
Q1
$647K Buy
8,356
+600
+8% +$46.5K ﹤0.01% 636
2019
Q4
$738K Sell
7,756
-37
-0.5% -$3.52K ﹤0.01% 694
2019
Q3
$594K Sell
7,793
-630
-7% -$48K ﹤0.01% 713
2019
Q2
$739K Buy
8,423
+167
+2% +$14.7K ﹤0.01% 690
2019
Q1
$747K Hold
8,256
﹤0.01% 877
2018
Q4
$592K Buy
8,256
+5,349
+184% +$384K ﹤0.01% 894
2018
Q3
$279K Hold
2,907
﹤0.01% 1175
2018
Q2
$277K Hold
2,907
﹤0.01% 1134
2018
Q1
$255K Sell
2,907
-303
-9% -$26.6K ﹤0.01% 1031
2017
Q4
$273K Buy
3,210
+303
+10% +$25.8K ﹤0.01% 1069
2017
Q3
$252K Buy
+2,907
New +$252K ﹤0.01% 1052
2014
Q2
Sell
-2,550
Closed -$121K 1007
2014
Q1
$121K Hold
2,550
﹤0.01% 905
2013
Q4
$111K Buy
+2,550
New +$111K ﹤0.01% 867